Vanguard Group Inc Applied Genetic Technologies Corp Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $146,139 - $448,496	-503,929 Reduced 25.43%	1,477,636 $401,000
Q1 2022 May 13, 2022	BUY	$1.07 - $2.71 $266,236 - $674,299	248,819 Added 14.36%	1,981,565 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $4,910 - $7,641	-2,626 Reduced 0.15%	1,732,746 $3.29 Million
Q2 2021 Aug 13, 2021	BUY	$3.62 - $5.23 $6.28 Million - $9.08 Million	1,735,372 New	1,735,372 $6.79 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.